You are here: Home » News-CM » Companies » News
Business Standard

Strides to acquire 80% stake in Canadian based Pharmapar Inc.

Capital Market 

Strides Pharma Science announced that its step down subsidiary, Strides Pharma Canada Inc, Canada on 29 January 2019 has entered into an arrangement to acquire 80% stake in Pharmapar Inc. (Pharmapar), a Canada based specialised generics front end Company for consideration of CAD 4 mn (~US$ 3 mn).

The board of directors of Strides have taken the same on record.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, January 29 2019. 14:15 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU